Jonathan J. Havel

Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer

Naiyer A. Rizvi, Matthew D. Hellmann, Alexandra Snyder et al. · Science · 2015 · 7.8K citations · Full text

Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab

Nadeem Riaz, Jonathan J. Havel, Vladimir Makarov et al. · Cell · 2017 · 2.5K citations · Full text

Microenvironment Evolution, Tumor Immunology, Cancer Immunosurveillance +6

The head and neck cancer immune landscape and its immunotherapeutic implications

Rajarsi Mandal, Yasin Şenbabaoğlu, Alexis Desrichard et al. · JCI Insight · 2016 · 773 citations · Full text

Genetic diversity of tumors with mismatch repair deficiency influences anti–PD-1 immunotherapy response

Rajarsi Mandal, Robert Samstein, Ken-Wing Lee et al. · Science · 2019 · 564 citations · Full text

Immunodeficiencies, Immunology, Pathology +16

Immunogenic neoantigens derived from gene fusions stimulate T cell responses

Wei Yang, Ken-Wing Lee, Raghvendra M. Srivastava et al. · Nature Medicine · 2019 · 371 citations

Autoimmune Disease, Adaptive Immune System, T-regulatory Cell +10